tert-butyl 2-(aminomethyl)-5,5-difluoropiperidine-1-carboxylate, 97.0%, 250mg

(R)-2-(Aminoethyl)-1-N-Boc-pyrrolidine, 97.0%, 250mg

tert-butyl 3-(2-aminoethyl)-4-morpholinecarboxylate, 95.0%, 100mg

(1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-6-(methoxymethoxy)-5,6-dimethylhept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)cyclohexane-1,3-diol, 98%, 25mg

1-(2-Methyl-4-nitrophenyl)ethanone, 95.0%, 10g

6-Chloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one, 95.0%, 1g

Methanol D3, 99.5 at%D, 1 ml, glass packagingamp.

D-(+)-Sucrose>99.0%(HPLC)25g

Ethyl 7-Chloroimidazo[1,2-a]pyridine-2-carboxylate, 97.0%, 100mg

BATIMASTAT, 95%, 10mg

3-(4-Bromophenyl)piperidine hydrochloride, 96%, 250mg

2-(2-((tert-Butoxycarbonyl)(methyl)amino)-N-methylacetamido)acetic acid, 97%, 5g

(S)-2-Chloropropanoic acid, 98.0%, 100g